(lp0
S"Abbott Laboratories Downgraded by MBO Yahoo Finance - Mar 14, 2017 MBO downgraded Abbott Laboratories  from outperform to market perform. The analysts' average target price is now $48 per share as reported by The Street.3 Reasons to Love Abbott Laboratories  Stock - Investorplace.com"
p1
aS"Abbott Laboratories closed with a change of -0.07% in the Previous Trading Session Free Observer - 18 hours ago If you look at the company's income statement over the past years, you will see that the company is constantly posting gross profit: In 2014, ABT earned gross profit of 11.05 Billion, in 2015 11.68 Billion gross profit, while in 2016 Abbott ...Hot Stock Overview: Abbott Laboratories  - HugoPressWhich insiders are selling Abbott Laboratories ? - Post Analyst"
p2
aS"Abbott Laboratories' MitraClip Outcome Positive for DMR Yahoo Finance - Mar 20, 2017 Global health care major Abbott Laboratories ABT recently presented one-year positive outcomes from the study of the MitraClip system in transcatheter mitral valve repair  procedures in the U.S.Abbott Laboratories subtracted -0.4% in its Stock Price in the Previous ... - Free ObserverAnalytical Guide for Abbott Laboratories , Delta Air Lines, Inc. (DAL ... - The USA Commerce"
p3
aS"Key Stocks of the Day: Abbott Laboratories  The News Journal - 10 hours ago As it reflects the theoretical cost of buying the company's shares, the market cap of Abbott Laboratories  is currently rolling at 77310.44, making it one of the key stocks in today's market."
p4
aS'Abbott Laboratories Stock Downgraded by BMO TheStreet.com - Mar 14, 2017 Abbot Laboratories  shares were downgraded to &quot;market perform&quot; from &quot;outperform&quot; by analysts at BMO Tuesday.'
p5
aS'BRIEF-Abbott Laboratories says CEO Miles White total compensation for 2016 $20 ... Reuters - Mar 17, 2017 March 17 Abbott Laboratories. * Abbott laboratories says chairman and ceo miles white total compensation for 2016 $20.3 million versus.'
p6
aS'Can Abbott Outperform Despite Alere? TheStreet.com - Mar 22, 2017 Alere has sued to force Abbott to obtain all antitrust approvals to complete the merger. Abbott, meanwhile, filed a countersuit to that action as well as another lawsuit last December looking to dump the deal, charging that Alere had lost much of its ...'
p7
aS"Abbott Laboratories'  Management Presents at Barclays Capital 2017 Global ... Seeking Alpha - Mar 16, 2017 All right. So, we're ready to get started with our next session here. And we're really pleased to be joined by management from Abbott Laboratories, including Brian Yoor, who is EVP of Finance and CFO. And Abbott has been our topic for about the six months."
p8
aS'Abbott Labs  Up 10.8% Since Earnings Report: Can It Continue? Nasdaq - Feb 27, 2017 Abbott Laboratories reported fourth-quarter 2016 earnings from continuing operations of $0.65 per share, $0.01 higher than the Zacks Consensus Estimate and up 4.8% year over year.Today Analysts Focus on GGP Inc. , Abbott Laboratories  - StockNewsJournalPrice Target Analysis: Abbott Laboratories  - News Oracle'
p9
aS'Abbott Laboratories Risk Points versus Health Care CML News - 20 hours ago This is a scatter plot analysis of the critical risk points from the option market for Abbott Laboratories  compared to its own past and the Health Care ETF.'
p10
a.